PATH is the leader in global health innovation. An international nonprofit organization, we save lives and improve health, especially among women and children. We accelerate innovation across five platforms—vaccines, drugs, diagnostics, devices, and system and service innovations—that harness our entrepreneurial insight, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, we take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. Together, we deliver measurable results that disrupt the cycle of poor health.
PATH focuses on activities that require urgent and immediate attention in preparation for the Technical and Market Lead (TML) official start and support a seamless transition to the TML mechanism. This effort includes: 1) Engaging with two high-priority countries (Mozambique, Zambia) and two lower-priority countries (DRC, Uganda, and in collaboration with JSI, Benin) to understand the existing landscape, establish/solidify partner relationships and roles, and identify support needs for subsequent DMPA SubQ introduction planning under the TML; provide virtual support to advance activities in all countries; and 2) Developing the initial suite of resources to support communication, planning, and monitoring.